Journal of Cystic Fibrosis
Scope & Guideline
Innovating treatments, transforming lives.
Introduction
Aims and Scopes
- CFTR Modulator Therapy:
A significant focus on the effectiveness and safety of CFTR modulators, including elexacaftor, tezacaftor, and ivacaftor, in treating various CF genotypes. - Microbiome Research:
Exploration of the cystic fibrosis microbiome, including its interactions with disease pathology and treatment responses, particularly regarding Pseudomonas aeruginosa and other pathogens. - Quality of Life and Patient-Centered Care:
Assessment of health-related quality of life and the psychosocial impact of cystic fibrosis on patients and their families, emphasizing the importance of holistic care. - Nutritional Management:
Research on dietary interventions, nutritional status, and gastrointestinal complications in cystic fibrosis, recognizing the critical role of nutrition in disease management. - Longitudinal Studies and Registries:
Utilization of registry data and longitudinal studies to understand disease progression, treatment outcomes, and long-term health implications for cystic fibrosis patients. - Clinical Guidelines and Standards of Care:
Development and dissemination of evidence-based clinical guidelines to improve standard care practices for cystic fibrosis patients across different demographics.
Trending and Emerging
- Telehealth and Digital Health Innovations:
An increasing number of studies are focusing on telehealth implementations and digital health tools to improve care delivery and patient engagement, especially in light of the COVID-19 pandemic. - Pharmacogenomics and Personalized Medicine:
Research into pharmacogenomic approaches is gaining traction, aiming to tailor CF treatments based on individual genetic profiles, thereby enhancing therapeutic efficacy. - Impact of Socioeconomic Factors:
Emerging themes are addressing the influence of socioeconomic factors on health outcomes in cystic fibrosis, emphasizing the need for equitable access to care and treatment. - Mental Health and Psychosocial Research:
There is a growing emphasis on mental health outcomes and the psychosocial impact of living with cystic fibrosis, highlighting the importance of addressing emotional well-being in treatment plans. - Longitudinal Outcomes of Novel Therapies:
Studies focusing on the long-term effectiveness and safety of recently approved therapies, particularly CFTR modulators, are becoming increasingly prevalent.
Declining or Waning
- Basic Science Research:
There has been a noticeable decrease in basic science studies focused solely on the pathology of cystic fibrosis, as the field shifts towards applied research and clinical trials. - Traditional Antibiotic Therapies:
Interest in conventional antibiotic therapies appears to be waning, likely due to the rise of new CFTR modulators and alternative treatment strategies that target the underlying cause of the disease. - Palliative Care Research:
Although still important, there seems to be less emphasis on palliative care studies compared to previous years, possibly overshadowed by advancements in curative and disease-modifying therapies. - Longitudinal Studies of Older Treatment Regimens:
Research focusing on the long-term efficacy of older treatment regimens, such as dornase alfa, is becoming less frequent as newer therapies dominate clinical discussions.
Similar Journals
Practical Radiation Oncology
Connecting Research with Real-World ApplicationsPractical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.
Saudi Journal of Gastroenterology
Empowering knowledge for better digestive health.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
EUROPEAN RESPIRATORY JOURNAL
Advancing the Frontiers of Respiratory MedicineThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
RHEUMATOLOGY INTERNATIONAL
Empowering researchers and clinicians with vital insights.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
Saudi Journal of Kidney Diseases and Transplantation
Fostering excellence in kidney research and clinical practice.Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.
DIGESTION
Delivering high-quality research to transform digestive health.DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.
Journal of Allergy and Clinical Immunology-In Practice
Unveiling breakthroughs in allergy care and treatment.The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.
Pain Management
Advancing the Future of Pain Relief.Pain Management, published by Future Medicine Ltd, is a premier journal that serves the fields of anesthesiology, pain medicine, and dentistry. With its ISSN 1758-1869 and E-ISSN 1758-1877, this journal is committed to advancing knowledge and practice through high-quality research articles, clinical studies, and expert reviews. The journal has established itself as a pivotal resource in pain management with a commendable impact factor and recognition in category quartiles, achieving Q2 rankings in Anesthesiology and Pain Medicine, as well as in miscellaneous Medicine and Dentistry categories as of 2023. Researchers and professionals will find a wealth of information in its comprehensive articles, which are essential for staying at the forefront of developments in pain management therapies and techniques. Although access is not open, the journal is recognized for its rigor and significance in shaping the future of pain management practices globally. Join the community of experts engaging in cutting-edge discussions by exploring the impactful research being published in this essential resource.
Advances in Rheumatology
Empowering discoveries in rheumatic disease management.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.
CUAJ-Canadian Urological Association Journal
Empowering Insights for the Future of Urology.CUAJ - Canadian Urological Association Journal is a premier, peer-reviewed journal dedicated to advancing the field of urology, published by the Canadian Urological Association. With its ISSN 1911-6470 and E-ISSN 1920-1214, the journal serves as a vital platform for disseminating high-quality research and clinical insights relevant to urology and oncology. Located in Canada, CUAJ is committed to publishing original research, reviews, and case studies that contribute to the scientific community's understanding of urological diseases and treatments. As of 2023, CUAJ holds a notable ranking of Q2 in Urology and Q3 in Oncology, reflecting its rigorous editorial standards and impactful contributions to the field, particularly acknowledged by its Scopus ranking as #61 in the Medicine and Urology category. Although primarily not an open-access journal, it aims to foster scholarly communication that empowers researchers, healthcare professionals, and students. With a rich history from its inception in 2007, CUAJ continues to play an integral role in shaping urological education and practice, making it an essential read for anyone involved in this dynamic field.